| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.00035 | 1 |